8-KOther EventsExhibits & Filings

Medtronic plc 8-K Report, Corporate Update (Sep 1, 2015)

Filed September 1, 2015For Securities:MDT

Summary

Medtronic plc filed an 8-K on September 1, 2015, to announce the results of several extensive exchange offers for its outstanding senior notes. These offers involved exchanging existing notes, originally issued by Medtronic, Inc. and guaranteed by Medtronic plc and Medtronic Global Holdings S.C.A., for newly issued, registered exchange notes with identical terms. This strategic move is primarily a compliance measure related to Medtronic's recent inversion transaction, ensuring that publicly traded debt instruments are held by the Irish parent company, Medtronic plc, and properly registered under the Securities Act. The exchange offers covered a significant principal amount across various maturity dates, totaling over $17 billion in potential exchanges, indicating a substantial restructuring of the company's debt obligations to align with its new corporate domicile.

Key Highlights

  • 1Medtronic plc announced the successful completion of multiple exchange offers for its senior notes.
  • 2The exchange offers involved swapping existing notes for newly issued, registered notes with identical terms and maturities.
  • 3This action is a key step in aligning the company's debt structure with its Irish corporate domicile following the recent inversion transaction.
  • 4The exchange offers covered a broad range of note maturities, from 2018 to 2045, with aggregate principal amounts up to $17.5 billion.
  • 5The registered exchange notes are guaranteed by Medtronic plc and Medtronic Global Holdings S.C.A.
  • 6This filing serves as a compliance update related to Medtronic's corporate structure changes.
  • 7The event date was August 31, 2015, with the report filed on September 1, 2015.

Frequently Asked Questions

The primary purpose was to ensure that Medtronic plc's publicly traded debt was held by the Irish parent company and properly registered, a necessary step following the company's inversion transaction which changed its corporate domicile to Ireland.

The exchange offers involved various series of Senior Notes, including Floating Rate Senior Notes due 2020, and fixed-rate Senior Notes due 2018, 2020, 2022, 2025, 2035, and 2045. These were originally issued by Medtronic, Inc.

No, the newly issued exchange notes had identical terms and maturities to the original notes they replaced. The exchange was essentially a registration compliance measure, not a change in debt terms or interest rates.

Registration under the Securities Act means the new notes have been officially registered with the Securities and Exchange Commission (SEC). This is generally required for securities that are publicly traded and is a key component of aligning the company's debt with its new Irish corporate structure.